Objectives: The features of a newly established, web-based surveillance system for hospital antibiotic consumption are described and data on broad-spectrum antibiotic use in German acute care hospitals are presented. Methods: The watch- and reserve-group antibiotics, two categories of antibiotics derived from the WHO Essential Medicines List comprising key agents for antimicrobial stewardship, were used as a framework for data analysis. The median antibiotic consumption densities (ACDs; DDD/100 patient days) for the years 2015/16 based on data from 137 acute care hospitals have been calculated for whole facilities, ICUs and medical and surgical departments, stratified by type of care. Results: The new web-based system provides real-time surveillance at unit and facility levels, accessible to all relevant stakeholders. User-defined reports are available via an interactive database, various report types support different approaches to analysis, and different complementing quantification measures of antimicrobial consumption are available. Watch- and reserve-group antibiotics accounted for 42% and 2% of total antibiotic use, respectively. Surgical services presented with considerably lower median ACDs of the watch-group antibiotics compared with medical services. Tertiary care hospitals exhibited higher ACDs of the reserve-group antibiotics and carbapenems than primary/secondary care hospitals, while the ACDs of the watch-group antibiotics as a whole did not differ significantly. Comparing the proportional use with other European countries revealed a relatively high use of the watch-group, ranking beyond the 75th percentile. Conclusions: Because of its particular features the new web-based surveillance system is a valuable tool for antimicrobial stewardship. The WHO categories of watch- and reserve-group antibiotics proved to be a useful framework for the analysis of hospital antibiotic consumption data.
Objectives: The features of a newly established, web-based surveillance system for hospital antibiotic consumption are described and data on broad-spectrum antibiotic use in German acute care hospitals are presented. Methods: The watch- and reserve-group antibiotics, two categories of antibiotics derived from the WHO Essential Medicines List comprising key agents for antimicrobial stewardship, were used as a framework for data analysis. The median antibiotic consumption densities (ACDs; DDD/100 patient days) for the years 2015/16 based on data from 137 acute care hospitals have been calculated for whole facilities, ICUs and medical and surgical departments, stratified by type of care. Results: The new web-based system provides real-time surveillance at unit and facility levels, accessible to all relevant stakeholders. User-defined reports are available via an interactive database, various report types support different approaches to analysis, and different complementing quantification measures of antimicrobial consumption are available. Watch- and reserve-group antibiotics accounted for 42% and 2% of total antibiotic use, respectively. Surgical services presented with considerably lower median ACDs of the watch-group antibiotics compared with medical services. Tertiary care hospitals exhibited higher ACDs of the reserve-group antibiotics and carbapenems than primary/secondary care hospitals, while the ACDs of the watch-group antibiotics as a whole did not differ significantly. Comparing the proportional use with other European countries revealed a relatively high use of the watch-group, ranking beyond the 75th percentile. Conclusions: Because of its particular features the new web-based surveillance system is a valuable tool for antimicrobial stewardship. The WHO categories of watch- and reserve-group antibiotics proved to be a useful framework for the analysis of hospital antibiotic consumption data.
Authors: Seven Johannes Sam Aghdassi; Frank Schwab; Sonja Hansen; Luis Alberto Peña Diaz; Michael Behnke; Petra Gastmeier; Tobias Siegfried Kramer Journal: Euro Surveill Date: 2019-11
Authors: Tobias Siegfried Kramer; Frank Schwab; Michael Behnke; Sonja Hansen; Petra Gastmeier; Seven Johannes Sam Aghdassi Journal: Antimicrob Resist Infect Control Date: 2019-10-21 Impact factor: 4.887
Authors: Maria Diletta Pezzani; Elena Carrara; Marcella Sibani; Elisabeth Presterl; Petra Gastmeier; Hanna Renk; Souha S Kanj; Thirumalaisamy P Velavan; Le Huu Song; Leonard Leibovici; Didem Torumkuney; Tomislav Kostyanev; Marc Mendelson; Evelina Tacconelli Journal: J Antimicrob Chemother Date: 2020-12-06 Impact factor: 5.790
Authors: Nam Vinh Nguyen; Nga Thi Thuy Do; Chuc Thi Kim Nguyen; Toan Khanh Tran; Phuc Dang Ho; Hanh Hong Nguyen; Huong Thi Lan Vu; Heiman F L Wertheim; H Rogier van Doorn; Sonia Lewycka Journal: JAC Antimicrob Resist Date: 2020-09-14
Authors: Jane Robertson; Vera Vlahović-Palčevski; Kotoji Iwamoto; Liselotte Diaz Högberg; Brian Godman; Dominique L Monnet; Sarah Garner; Klaus Weist Journal: Front Pharmacol Date: 2021-06-17 Impact factor: 5.810
Authors: Annemieke K van den Broek; Berend H H Beishuizen; Eric A F Haak; Michiel Duyvendak; Jaap Ten Oever; Chris Sytsma; Mieke van Triest; Cornelia C H Wielders; Jan M Prins Journal: Antimicrob Resist Infect Control Date: 2021-07-03 Impact factor: 4.887